HazMat Fee +
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of NNK
CAS No.: 64091-91-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
NNK is a nitrosation derivative of nicotine that activates ERK1/2 and PKCα, and activates Bcl2 phosphorylation at Ser70, and c-Myc at Thr58 and Ser62. NNK can induce the proliferation and survival of human lung cancer cells and is used to construct a mouse model of lung cancer.
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Systematic analysis of gut bacterial carcinogen metabolism and its functional consequences
Boyao Zhang ; George-Eugen Maftei ; Bartosz Bartmanski ; Michael Zimmermann ;
Abstract: Organic carcinogens, in particular DNA-reactive compounds, contribute to the irreversible initiation step of tumorigenesis through introduction of genomic instability. Although carcinogen bioactivation and detoxification by human enzymes has been extensively studied, carcinogen biotransformation by human-associated bacteria, the microbiota, has not yet been systematically investigated. We tested the biotransformation of 68 mutagenic carcinogens by 34 bacterial species representative for the upper and lower human gastrointestinal tract and found that the majority (41) of the tested carcinogens undergo bacterial biotransformation. To assess the functional consequences of microbial carcinogen metabolism, we developed a pipeline to couple gut bacterial carcinogen biotransformation assays with Ames mutagenicity testing and liver biotransformation experiments. This revealed a bidirectional crosstalk between gut microbiota and host carcinogen metabolism, which we validated in gnotobiotic mouse models. Overall, the systematic assessment of gut microbiota carcinogen biotransformation and its interplay with host metabolism highlights the gut microbiome as an important modulator of exposome-induced tumorigenesis.
Show More >
Purchased from AmBeed: 446-86-6 ; 121-66-4 ; 607-35-2 ; 67-20-9 ; 105650-23-5 ; 59-87-0 ; 117-39-5 ; 57-97-6 ; 5131-60-2 ; 512-56-1 ; 62-44-2 ; 6959-48-4 ; 84-65-1 ; 137-17-7 ; 117-39-5 ; 153-78-6 ; 1614-12-6 ; 298-81-7 ; 404-86-4 ; 320-67-2 ; 99-55-8 ; 94-52-0 ; 2832-40-8 ; 101-61-1 ; 103-33-3 ; 114-83-0 ; 64091-91-4 ; 53-96-3 ; 3817-11-6 ; 90-94-8 ; 613-13-8 ; 56-57-5 ; 91-64-5 ; 26148-68-5 ; 101-80-4 ; 139-65-1 ; 366-70-1 ; 389-08-2 ; 99-59-2 ; 132-32-1 ; 394-69-4 ; 3544-23-8 ; 389-08-2 ; 320-67-2 ; 82-28-0 ; 2475-45-8 ; 129-15-7
Show More >
| CAS No. : | 64091-91-4 |
| Formula : | C10H13N3O2 |
| M.W : | 207.23 |
| SMILES Code : | O=C(C1=CC=CN=C1)CCCN(N=O)C |
| MDL No. : | MFCD00274580 |
| InChI Key : | FLAQQSHRLBFIEZ-UHFFFAOYSA-N |
| Pubchem ID : | 47289 |
| GHS Pictogram: |
|
| Signal Word: | Danger |
| Hazard Statements: | H301-H317-H351 |
| Precautionary Statements: | P280-P301+P310 |
| Class: | 6.1 |
| UN#: | 2811 |
| Packing Group: | Ⅲ |
| Description |
NNK, a nitrosated derivative of nicotine, concurrently induces phosphorylation of Bcl2 uniquely at Ser70 and c-Myc at Thr58 and Ser62 via activation of both ERK1/2 and PKCα[1].
|
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| MLE-12 cells | 10 µM | 24 hours | NNK significantly increased AGT protein expression. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| DMS79 cells | 10 µM | 48 and 72 hours | NNK treatment significantly increased DNMT1 expression | Sci Rep. 2018 Mar 20;8(1):4903 |
| A549 | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| Bet1A | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| NCI-H23 | 10 mM | 12 hours | NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. | iScience. 2023 Jul 27;26(8):107477 |
| Alveolar type II cells | 0.1 µM and 1.2 µM | 180 minutes | To study the metabolism of NNK in the lung and the distribution of its metabolites, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. | Drug Metab Dispos. 2010 May;38(5):752-60 |
| HBEL/p53i cells | 10 µM | 2 weeks | NNK significantly increased foci formation, which was significantly abrogated by treatment with an ACE inhibitor or AGTR1 antagonist. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| BEAS-2B cells | 10 µM | 24 hours | NNK induced AGT expression and secretion of AngII, leading to the acquisition of transformed phenotypes in lung epithelial cells. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| H1299 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| A549 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| IMR90 | 10 µM | 24 hours | NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters | J Clin Invest. 2010 Feb;120(2):521-32 |
| BEAS-2B cells | 50, 100, 200 mg/L | 24 hours | To detect the expression level of RRM2-C2orf48 in BEAS-2B cells after NNK treatment, results showed that 200 mg/L dose significantly upregulated RRM2-C2orf48 expression | iScience. 2022 Dec 2;26(1):105708 |
| BEAS-2B cells | 50, 100, 200, 400 mg/L | 24 hours | To assess the effect of NNK on the viability of BEAS-2B cells, results showed that NNK reduced cell viability in a dose-dependent manner | iScience. 2022 Dec 2;26(1):105708 |
| H1299 cells | 100 pM | 24 hours | NNK significantly enhances migration and invasion of H1299 cells and accelerates wound healing. | Cancer Lett. 2012 May 1;318(1):106-13 |
| B-Vector cells | 265.04 µM | 24 hours | Evaluate the cytotoxicity of NNK in B-Vector cells, results showed B-Vector cells were moderately sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| B-2A13 cells | 24.52 µM | 24 hours | Evaluate the cytotoxicity of NNK in B-2A13 cells, results showed B-2A13 cells were more sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| BEAS-2B cells | 376.14 µM | 24 hours | Evaluate the cytotoxicity of NNK in BEAS-2B cells, results showed BEAS-2B cells were less sensitive to NNK | Molecules. 2022 Jul 29;27(15):4851 |
| FaDu (human hypopharyngeal squamous cancer cells) | 1 µM and 2 µM | 24 hours | To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in FaDu cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. | Cells. 2020 Apr 21;9(4):1031 |
| NCI-H1703 (human lung squamous cancer cells) | 1 µM and 2 µM | 24 hours | To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in NCI-H1703 cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. | Cells. 2020 Apr 21;9(4):1031 |
| Het-1A cells | 1 µM | 24 hours | NNK stimulated expression of oncogenic genes, including ETS1, NRAS and SRC, which could be abolished in the presence of rSLURP-1. | Life Sci. 2012 Nov 27;91(21-22):1122-5 |
| BEP2D cells | 1 µM | 24 hours | NNK stimulated expression of oncogenic genes, including MYB and PIK3CA, which could be abolished in the presence of rSLURP-1. | Life Sci. 2012 Nov 27;91(21-22):1122-5 |
| MRC-5 cells | 10 µM | 24, 48, and 72 hours | NNK treatment significantly reduced GRα mRNA and protein expression levels and caused accumulation of DNMT1 at GR promoters 1B and 1F | Sci Rep. 2018 Mar 20;8(1):4903 |
| Panc-1 | 1 µM | 24-48 hours | NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. | Mol Oncol. 2022 Aug;16(15):2881-2895 |
| BxPC-3 | 1 µM | 24-48 hours | NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. | Mol Oncol. 2022 Aug;16(15):2881-2895 |
| NCI-H23 cells | 10 µM | 28 days | To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression | J Transl Med. 2020 Feb 11;18(1):66 |
| Bet1A cells | 10 µM | 28 days | To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression | J Transl Med. 2020 Feb 11;18(1):66 |
| Beas-2B | 10 µM | 6 hours | DNMT1 protein returned to basal levels 2–6 hours after discontinuation of NNK treatment | J Clin Invest. 2010 Feb;120(2):521-32 |
| LLC | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| EPLC-32M | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| A549 | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| 16HBE | 25 µM | 72 hours | NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| CAL-27 cells | 5 µM | 96 hours | NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. | Am J Cancer Res. 2020 Jun 1;10(6):1745-1760 |
| HSC-3 cells | 5 µM | 96 hours | NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. | Am J Cancer Res. 2020 Jun 1;10(6):1745-1760 |
| 2B-NNK cells | 100 mg/L | multiple exposures | To evaluate the effect of RRM2-C2orf48 overexpression on NNK-induced malignant transformation of BEAS-2B cells, results showed that RRM2-C2orf48 overexpression accelerated malignant transformation | iScience. 2022 Dec 2;26(1):105708 |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| Fischer 344 rats | Isolated perfused rat lung (IPRL) model | Perfusion | 0.1 μM and 1.2 μM | Single perfusion, lasting 180 minutes | To study the metabolism of NNK in the lung and the formation of DNA adducts, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. The addition of PEITC significantly reduced the formation of oxidative metabolites and increased the formation of NNAL and the percentage of unmetabolized NNK. PEITC also significantly decreased the formation of DNA adducts in the lung tissue. | Drug Metab Dispos. 2010 May;38(5):752-60 |
| Mice | NNK-induced lung cancer model and K-rasLA1 transgenic mice | Intravenous injection | 10 μM | Once a week for 13 weeks (NNK model) or 5 weeks (K-rasLA1 model) | MiR-124 agomiR significantly suppressed NNK-induced and K-ras mutation-driven lung tumorigenesis | Mol Ther Nucleic Acids. 2017 Dec 15;9:145-154 |
| A/J mice | NNK-induced lung adenocarcinoma model | Intraperitoneal injection | 100 mg/kg | Every other day, three times, lasting for 16 weeks | NNK promoted lung adenocarcinoma development through CD36. | iScience. 2023 Jul 27;26(8):107477 |
| A/J mice | A/J mice | Intraperitoneal injection | 100 mg/kg | Single injection | To evaluate the protective effect of HB diet against NNK-induced lung tumorigenesis, results showed HB downregulated cyp2a4 and cyp2a5 mRNA expression and facilitated the formation of non-carcinogenic NNK metabolites | Pharmaceuticals (Basel). 2024 Nov 30;17(12):1615 |
| Mice | Pten +/− mice | Intraperitoneal injection | 100 mg/kg | Single dose or three doses weekly, lasting 16-24 weeks | To evaluate the effect of NNK on lung tumorigenesis in Pten +/? mice. Results showed that in lung tumor-susceptible pseudo–A/J mice, NNK treatment led to increased lung tumor size in Pten +/? mice but did not increase tumor multiplicity. In lung tumor-resistant C57BL/6 mice, NNK treatment did not induce lung tumors. | Neoplasia. 2008 Aug;10(8):866-72 |
| A/J and C3H mice | Lung tumor model | Intraperitoneal injection | 100 mg/kg/day | Every other day for three doses | To study the effect of NNK on lung tumorigenesis in A/J and C3H mice. Results showed that NNK induced lung tumors in A/J mice but not in C3H mice. | Am J Respir Cell Mol Biol. 2007 Jan;36(1):13-9 |
| A/J mice | Lung adenoma model | Intraperitoneal injection | 2 mg | Single injection, terminated 24 weeks after treatment | NNK induced increased expression levels of DNMT1, p-AKTser473, p-GSK3βser9, cytoplasmic hnRNP-U, and cytoplasmic βTrCP proteins | J Clin Invest. 2010 Feb;120(2):521-32 |
| Mice | Agt+/+ and Agt+/- mice | Oral gavage | 3 μmol | Twice a week for 20 weeks | NNK significantly increased the multiplicity, volume, and load of lung tumor nodules, and these changes were significantly suppressed in Agt+/- mice. | Exp Mol Med. 2023 Jun;55(6):1131-1144 |
| A/J mice | NNK-induced lung cancer model | Injection | 50 mg/kg | Twice, one week apart, for 20 weeks | To compare the efficacy of different fat types in ketogenic diets in preventing NNK-induced lung cancer. Results showed that the fish oil-enriched ketogenic diet (FO-KD) was most effective in reducing lung nodule numbers. | Sci Rep. 2024 Mar 7;14(1):5610 |
| A/J mice | Lung cancer model | Gavage | 50 mg/kg | Twice a week for 5 weeks | NNK significantly upregulated IDO1 expression in lung tissues and reduced CD8+T cells while increasing Tregs. | Signal Transduct Target Ther. 2022 Sep 7;7(1):311 |
| Ferrets (Mustela putorius furo) | Human lung cancer model | Intraperitoneal injection | 50 mg/kg | Once a month for four consecutive months, followed by observation for 24, 26, and 32 weeks | To investigate whether NNK exposure alone induces both preneoplastic and neoplastic lesions in ferret lungs. Results showed that NNK exposure led to preneoplastic lesions (squamous metaplasia, dysplasia, and atypical adenomatous hyperplasia) and tumors (squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma) in ferret lungs, with tumor incidence being time-dependent (16.7%, 40.0%, and 66.7% at 24, 26, and 32 weeks, respectively). Additionally, NNK exposure significantly increased α7 nAChR protein expression and showed a tendency for increased phospho-ERK and cyclin D1 protein levels. | Lung Cancer. 2013 Dec;82(3):390-6 |
| A/J mice | NNK-induced lung cancer model | Intraperitoneal injection | 50 mg/kg | Two injections, one week apart, for 20 weeks | To investigate the inhibitory effect of soy saponins and isoflavones on NNK-induced lung nodule formation. Results showed that the combination of soy saponins and isoflavones significantly reduced the number of lung nodules and increased plasma isoflavone levels. | Sci Rep. 2025 Apr 13;15(1):12714 |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.83mL 0.97mL 0.48mL |
24.13mL 4.83mL 2.41mL |
48.26mL 9.65mL 4.83mL |
|
| Dissolving Methods |
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||
Tags: NNK | Endogenous Metabolite | Nicotine-nitrosated derivative | Lung cancer | Bcl2 | c-Myc | Phosphorylation | Cell proliferation | inhibitor | 64091-91-4 |
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


